
zzso contraceptive use increases risk for zzso zzso but data on the effect of zzso hormone therapy are zzso 

To determine the effect of therapy with zzso plus zzso on risk for zzso zzso events in zzso zzso 

zzso zzso zzso zzso 

20 clinical centers in the United zzso 

zzso zzso women younger than 80 years of age zzso age, 67 zzso who had coronary heart disease but no previous zzso zzso and had not had a zzso 

zzso zzso zzso zzso zzso plus zzso zzso zzso zzso in one tablet zzso zzso zzso or zzso that was identical in appearance zzso zzso zzso 

zzso deep zzso zzso or pulmonary zzso 

During an average of zzso years of zzso 34 women in the hormone therapy group and 13 in the zzso group experienced zzso zzso events zzso zzso zzso zzso zzso zzso to zzso zzso zzso zzso excess risk, zzso per 1000 zzso zzso zzso to zzso per 1000 zzso number needed to treat for harm, 256 zzso 157 to zzso In zzso analysis, the risk for zzso zzso was increased among women who had zzso fractures zzso zzso zzso zzso zzso to zzso or cancer zzso zzso zzso zzso zzso to zzso and for 90 days after zzso surgery zzso zzso zzso zzso zzso to zzso or zzso hospitalization zzso zzso zzso zzso zzso to zzso zzso was decreased with aspirin zzso zzso zzso zzso zzso to zzso or zzso use zzso zzso zzso zzso zzso to zzso 

zzso therapy with zzso plus zzso increases risk for zzso zzso in women with coronary heart zzso This risk should be considered when the risks and benefits of therapy are being zzso 

